Table 1.
Correlation between ACP5 Expression and Clinicopathological Features in LUAD
| ACP5 |
||||
|---|---|---|---|---|
| All Cases | Low Expression | High Expression | p Valuea | |
| Sex | 0.334 | |||
| Male | 31 | 15 (21.73%) | 16 (23.19%) | |
| Female | 38 | 14 (20.29%) | 24 (34.78%) | |
| Ageb | 0.044 | |||
| ≤58 | 33 | 18 (26.09%) | 15 (21.74%) | |
| >58 | 36 | 11 (15.94%) | 25 (36.23%) | |
| Smoking | 0.863 | |||
| Never | 46 | 19 (27.54%) | 27 (39.13%) | |
| Current or past smoker | 23 | 10 (14.49%) | 13 (18.84%) | |
| Differentiation | 0.233 | |||
| Well | 22 | 6 (8.70%) | 16 (23.19%) | |
| Moderately | 23 | 11 (15.94%) | 12 (17.39%) | |
| Poorly | 24 | 12 (17.39%) | 12 (17.39%) | |
| Stage | ||||
| T staging | 0.886 | |||
| IA, IB | 7 | 4 (5.80%) | 3 (4.35%) | |
| IC | 19 | 7 (10.14%) | 12 (17.39%) | |
| IIA | 28 | 11 (15.94%) | 17 (24.63%) | |
| IIB | 7 | 3 (4.35%) | 4 (5.80%) | |
| III, IV | 8 | 4 (5.80%) | 4 (5.80%) | |
| N staging | 0.139 | |||
| 0 | 39 | 17 (24.84%) | 22 (31.88%) | |
| 1 | 11 | 7 (10.14%) | 4 (5.80%) | |
| 2–3 | 19 | 5 (7.25%) | 14 (20.29%) | |
| M staging | 0.389 | |||
| 0 | 64 | 28 (40.58%) | 36 (52.17%) | |
| 1 | 5 | 1 (1.45%) | 4 (5.80%) | |
LUAD, lung adenocarcinoma; T, tumor; N, node; M, metastasis.
a
The Pearson χ2 test or Fisher’s exact test was used for statistical analysis.
b
The mean age at diagnosis is 58.8 years in LUAD patients. Samples are divided into two groups based on the mean age.